Cymbalta med temp - ATI PDF

Preview

Summary

ATI...

Description

ACTIVE LEARNING TEMPLATE:

Medication

Diaz STUDENT NAME Cristina _____________________________________ (Cymbalta) MEDICATION duloxetine __________________________________________________________________________ REVIEW MODULE CHAPTER4/6/21 ___________ CATEGORY CLASS Serotonin-norepinephrine ______________________________________________________________________

PURPOSE OF MEDICATION

Expected Pharmacological Action Action SNRIs block reuptake of norepinephrine as well as serotonin with effects similar to the SSRIs.

Therapeutic Use Major depression, Generalized anxiety disorder, Social anxiety disorder, Panic disorder, Pain due to fibromyalgia, osteoarthritis, low-back pain, diabetic neuropathy (duloxetine; unlabeled use for venlafaxine)

Complications Nausea, anorexia, weight loss - Headache, insomnia, anxiety Hypertension, tachycardia - Dizziness, blurred vision - Withdrawal syndrome - Risk for suicide in children and adolescents - Sexual dysfunction - Serotonin syndrome - Bronchitis, dyspnea

Medication Administration ral only Contraindications/Precautions - These medications are pregnancy category risk C. Avoid during the third trimester and avoid breastfeeding while taking an SNRI. - SNRIs are contraindicated in clients taking SSRIs, MAOIs, or TCAs. SNRIs need to be discontinued at least 2 weeks before initiating an MAOI. - Precautions are needed for older adults, and clients who have bipolar disorder, mania, seizure disorder, recent MI, or interstitial lung disease.

Contraindications/Precautions Fatigue, drowsiness, insomnia, decrease appetite, constipation, dry mouth, nausea, increased sweating

Interactions

Nursing Interventions Monitor closely for notable changes in behavior that could indicate emergence or worsening of suicidal thoughts or behavio or depressionAssess for serotonin syndromeAssess for rash periodically during therapyFatigue, drowsiness, insomnia, decrease appetite, constipation, dry mouth, nausea, increased sweatingConcurrent use with MAO inhibitors may result in serious potentiallyfatal reactions, may increase the risk of serotonin syndrome, risk of hepatotoxicity with alcohol use disorderIncreased sense of well-being, renewed interest in surroundings,

Concurrent use with MAO inhibitors may result in serious potentiallyfatal reactions, may increase the risk of serotonin syndrome, risk of hepatotoxicity with alcohol use disorder Client Education Evaluation of Medication Effectiveness Verbalizing improvement in mood - Increased hopefulness and will to live - Ability to perform ADLs - Improved sleeping and eating habits - Increased interaction with peers

ACTIVE LEARNING TEMPLATES

Instruct clients to continue therapy after achieving therapeutic effects. Sudden discontinuation of medication can result in relapse. - Advise clients to take medication in the morning to minimize sleep disturbances. - Advise clients to take medications with food to minimize GI disturbances. - Advise clients about potential sexual side effects. - Avoid use of MAOIs....